Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke

Stroke

Volumn 31, Issue 11, 2000, Pages 2552-2557

  Ernst, Robert ^a   Pancioli, Arthur ^a   Tomsick, Thomas ^a   Kissela, Brett ^a   Woo, Daniel ^a   Kanter, Daniel ^a   Jauch, Edward ^a   Carrozzella, Janice ^a   Spilker, Judith ^a   Broderick, Joseph ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Fibrinolysis; Stroke, acute; Stroke, ischemic; Thrombolysis; Tissue plasminogen activator

Indexed keywords

ALTEPLASE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033761912     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.11.2552     Document Type: Article

References (14)

1. Tissue plasminogen activator for acute ischemic stroke
2. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
3. Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial
4. Combined intravenous and intra-arterial r-tPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial
5. Special report: The Thrombolysis in Myocardial Infarction (TIMI) Trial
6. Earlier treatment associated with better outcome in the NINDS TPA Stroke Study
7. The Greater Cincinnati T-PA experience after the NINDS trial: Does a longer time to treatment within the current three-hour window reduce efficacy?
8. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II Study: A randomized controlled trial
9. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators: Prolyse in Acute Cerebral Thromboembolism
10. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke
11. Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT
12. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke
13. A safety and efficacy study of intravenous rt-PA in patients with acute stroke